Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Streptococcus pneumoniae | 65 | 2021 | 764 | 9.920 |
Why?
|
Pneumococcal Infections | 43 | 2020 | 529 | 8.320 |
Why?
|
Pneumococcal Vaccines | 34 | 2021 | 414 | 5.920 |
Why?
|
Genome, Bacterial | 30 | 2024 | 796 | 4.090 |
Why?
|
Recombination, Genetic | 26 | 2020 | 1525 | 3.190 |
Why?
|
Bacteria | 26 | 2024 | 2216 | 2.970 |
Why?
|
Carrier State | 23 | 2020 | 529 | 2.940 |
Why?
|
Vaccines, Conjugate | 15 | 2020 | 334 | 2.650 |
Why?
|
Disease Outbreaks | 19 | 2021 | 1761 | 2.160 |
Why?
|
Phylogeny | 36 | 2022 | 2843 | 2.080 |
Why?
|
Serotyping | 28 | 2021 | 331 | 1.960 |
Why?
|
Escherichia coli Infections | 8 | 2020 | 524 | 1.860 |
Why?
|
Molecular Epidemiology | 10 | 2020 | 473 | 1.740 |
Why?
|
Evolution, Molecular | 22 | 2020 | 1896 | 1.730 |
Why?
|
Genetic Variation | 29 | 2020 | 6611 | 1.710 |
Why?
|
Metagenomics | 7 | 2024 | 474 | 1.480 |
Why?
|
Drug Resistance, Bacterial | 15 | 2021 | 1063 | 1.430 |
Why?
|
Genetic Speciation | 6 | 2017 | 38 | 1.330 |
Why?
|
Genomics | 14 | 2024 | 5925 | 1.290 |
Why?
|
Anti-Bacterial Agents | 27 | 2021 | 7470 | 1.270 |
Why?
|
Bacterial Typing Techniques | 11 | 2020 | 263 | 1.180 |
Why?
|
Gene Transfer, Horizontal | 9 | 2021 | 148 | 1.170 |
Why?
|
Penicillin Resistance | 3 | 2017 | 77 | 1.150 |
Why?
|
Genes, Bacterial | 13 | 2021 | 1076 | 1.060 |
Why?
|
Drug Resistance, Multiple, Bacterial | 11 | 2020 | 591 | 1.040 |
Why?
|
Models, Genetic | 15 | 2017 | 3447 | 0.990 |
Why?
|
Science | 2 | 2020 | 236 | 0.950 |
Why?
|
Biological Evolution | 8 | 2017 | 1076 | 0.880 |
Why?
|
Escherichia coli | 6 | 2020 | 4215 | 0.840 |
Why?
|
Mass Vaccination | 3 | 2021 | 111 | 0.810 |
Why?
|
Immunity, Herd | 2 | 2021 | 48 | 0.780 |
Why?
|
beta-Lactam Resistance | 3 | 2017 | 79 | 0.760 |
Why?
|
Neisseria | 3 | 2013 | 13 | 0.750 |
Why?
|
Genetics, Population | 8 | 2018 | 943 | 0.750 |
Why?
|
Multilocus Sequence Typing | 9 | 2015 | 102 | 0.740 |
Why?
|
DNA, Bacterial | 14 | 2018 | 1478 | 0.710 |
Why?
|
Communicable Diseases | 6 | 2021 | 874 | 0.710 |
Why?
|
Bacteremia | 4 | 2019 | 986 | 0.710 |
Why?
|
Selection, Genetic | 11 | 2021 | 877 | 0.700 |
Why?
|
beta-Lactams | 3 | 2020 | 158 | 0.670 |
Why?
|
Streptococcus | 3 | 2014 | 198 | 0.660 |
Why?
|
Directed Molecular Evolution | 1 | 2020 | 167 | 0.650 |
Why?
|
Microbial Sensitivity Tests | 12 | 2020 | 1967 | 0.630 |
Why?
|
Cross Infection | 6 | 2019 | 1426 | 0.620 |
Why?
|
Federal Government | 1 | 2020 | 266 | 0.620 |
Why?
|
Genotype | 21 | 2021 | 13042 | 0.610 |
Why?
|
Sequence Analysis, DNA | 17 | 2020 | 4785 | 0.610 |
Why?
|
Infectious Disease Transmission, Patient-to-Professional | 1 | 2021 | 249 | 0.600 |
Why?
|
Nasopharynx | 12 | 2020 | 420 | 0.600 |
Why?
|
Mycobacterium tuberculosis | 2 | 2020 | 1930 | 0.600 |
Why?
|
Epidemiology | 2 | 2018 | 278 | 0.590 |
Why?
|
Genome, Viral | 2 | 2020 | 674 | 0.590 |
Why?
|
Streptococcus pyogenes | 1 | 2020 | 293 | 0.590 |
Why?
|
Social Responsibility | 1 | 2020 | 382 | 0.590 |
Why?
|
DNA Transposable Elements | 5 | 2021 | 764 | 0.580 |
Why?
|
Staphylococcus aureus | 7 | 2018 | 1430 | 0.580 |
Why?
|
R Factors | 1 | 2017 | 35 | 0.560 |
Why?
|
Clinical Medicine | 1 | 2018 | 145 | 0.560 |
Why?
|
Pandemics | 11 | 2021 | 8748 | 0.560 |
Why?
|
Adaptation, Biological | 1 | 2018 | 147 | 0.560 |
Why?
|
Vaccination | 10 | 2021 | 3437 | 0.540 |
Why?
|
Shiga-Toxigenic Escherichia coli | 2 | 2015 | 26 | 0.540 |
Why?
|
Meningococcal Vaccines | 2 | 2007 | 96 | 0.530 |
Why?
|
Staphylococcal Infections | 6 | 2018 | 1398 | 0.530 |
Why?
|
Cluster Analysis | 11 | 2017 | 2731 | 0.520 |
Why?
|
Contact Tracing | 4 | 2021 | 275 | 0.510 |
Why?
|
Carbapenems | 1 | 2017 | 125 | 0.510 |
Why?
|
Epistasis, Genetic | 1 | 2018 | 353 | 0.500 |
Why?
|
Prophages | 2 | 2014 | 39 | 0.500 |
Why?
|
Enterobacteriaceae | 1 | 2017 | 161 | 0.500 |
Why?
|
Genomic Islands | 2 | 2014 | 52 | 0.490 |
Why?
|
Host-Pathogen Interactions | 5 | 2017 | 1469 | 0.490 |
Why?
|
Enterobacteriaceae Infections | 1 | 2017 | 190 | 0.470 |
Why?
|
Bacterial Load | 1 | 2015 | 155 | 0.470 |
Why?
|
Influenza A virus | 1 | 2018 | 460 | 0.460 |
Why?
|
Communicable Disease Control | 4 | 2021 | 857 | 0.460 |
Why?
|
Bacterial Infections | 7 | 2015 | 1397 | 0.450 |
Why?
|
Ecosystem | 5 | 2017 | 494 | 0.450 |
Why?
|
Penicillins | 1 | 2017 | 404 | 0.450 |
Why?
|
Bacterial Capsules | 5 | 2017 | 247 | 0.440 |
Why?
|
Infection Control | 1 | 2021 | 985 | 0.440 |
Why?
|
Massachusetts | 16 | 2021 | 8888 | 0.430 |
Why?
|
Bacterial Vaccines | 1 | 2015 | 400 | 0.420 |
Why?
|
High-Throughput Nucleotide Sequencing | 5 | 2020 | 3669 | 0.410 |
Why?
|
Humans | 125 | 2022 | 767991 | 0.410 |
Why?
|
Archaea | 1 | 2013 | 60 | 0.410 |
Why?
|
Hemorrhagic Fever, Ebola | 1 | 2017 | 424 | 0.400 |
Why?
|
Haemophilus influenzae | 1 | 2012 | 177 | 0.400 |
Why?
|
Methicillin-Resistant Staphylococcus aureus | 6 | 2018 | 704 | 0.390 |
Why?
|
Zoonoses | 1 | 2013 | 180 | 0.390 |
Why?
|
Polymorphism, Single Nucleotide | 12 | 2020 | 16041 | 0.390 |
Why?
|
Tuberculosis, Pulmonary | 1 | 2018 | 843 | 0.380 |
Why?
|
Indians, North American | 2 | 2012 | 354 | 0.380 |
Why?
|
Models, Biological | 8 | 2020 | 9493 | 0.370 |
Why?
|
Species Specificity | 6 | 2015 | 2415 | 0.370 |
Why?
|
Neisseria gonorrhoeae | 3 | 2020 | 249 | 0.370 |
Why?
|
Cell Communication | 1 | 2018 | 1660 | 0.360 |
Why?
|
Influenza, Human | 3 | 2018 | 1541 | 0.360 |
Why?
|
Infant | 27 | 2022 | 36534 | 0.360 |
Why?
|
Biodiversity | 2 | 2014 | 345 | 0.360 |
Why?
|
Classification | 2 | 2009 | 128 | 0.340 |
Why?
|
Uncertainty | 2 | 2014 | 769 | 0.340 |
Why?
|
Fuzzy Logic | 2 | 2011 | 58 | 0.340 |
Why?
|
Models, Theoretical | 4 | 2021 | 3573 | 0.340 |
Why?
|
Ontario | 3 | 2020 | 403 | 0.340 |
Why?
|
Computer Simulation | 11 | 2021 | 6283 | 0.330 |
Why?
|
Seroepidemiologic Studies | 2 | 2021 | 404 | 0.330 |
Why?
|
Population Dynamics | 5 | 2018 | 314 | 0.310 |
Why?
|
Famous Persons | 1 | 2009 | 109 | 0.310 |
Why?
|
Otitis Media | 3 | 2008 | 288 | 0.310 |
Why?
|
Child, Preschool | 24 | 2019 | 42665 | 0.300 |
Why?
|
Public Health | 4 | 2021 | 2679 | 0.300 |
Why?
|
Bacterial Proteins | 9 | 2018 | 3841 | 0.290 |
Why?
|
Chromosome Mapping | 4 | 2014 | 4618 | 0.280 |
Why?
|
Tuberculosis | 1 | 2020 | 2029 | 0.270 |
Why?
|
Antibodies | 1 | 2015 | 2421 | 0.270 |
Why?
|
Epidemics | 3 | 2021 | 517 | 0.270 |
Why?
|
Interspersed Repetitive Sequences | 2 | 2019 | 52 | 0.260 |
Why?
|
China | 3 | 2021 | 2395 | 0.260 |
Why?
|
Coronavirus Infections | 5 | 2020 | 3115 | 0.250 |
Why?
|
Pneumonia, Viral | 5 | 2020 | 3238 | 0.250 |
Why?
|
Sampling Studies | 2 | 2021 | 615 | 0.250 |
Why?
|
Area Under Curve | 3 | 2020 | 1642 | 0.240 |
Why?
|
Plasmids | 5 | 2021 | 2269 | 0.240 |
Why?
|
Antibodies, Bacterial | 4 | 2018 | 1478 | 0.230 |
Why?
|
Bayes Theorem | 6 | 2018 | 2358 | 0.220 |
Why?
|
Child | 25 | 2020 | 80906 | 0.210 |
Why?
|
Sequence Alignment | 3 | 2017 | 2178 | 0.200 |
Why?
|
History, 21st Century | 2 | 2018 | 1572 | 0.200 |
Why?
|
Antigens, Bacterial | 2 | 2017 | 1150 | 0.190 |
Why?
|
Conjugation, Genetic | 1 | 2021 | 116 | 0.180 |
Why?
|
Computational Biology | 4 | 2021 | 3568 | 0.180 |
Why?
|
Databases, Genetic | 4 | 2020 | 1758 | 0.180 |
Why?
|
Hong Kong | 1 | 2020 | 170 | 0.170 |
Why?
|
ROC Curve | 3 | 2019 | 3628 | 0.170 |
Why?
|
Mandatory Reporting | 1 | 2021 | 123 | 0.170 |
Why?
|
Population Density | 2 | 2014 | 193 | 0.170 |
Why?
|
Communicable Diseases, Emerging | 1 | 2021 | 149 | 0.160 |
Why?
|
Livestock | 1 | 2019 | 20 | 0.160 |
Why?
|
Prevalence | 9 | 2018 | 15867 | 0.160 |
Why?
|
Gram-Positive Bacterial Infections | 2 | 2012 | 342 | 0.160 |
Why?
|
Methicillin Resistance | 2 | 2018 | 198 | 0.160 |
Why?
|
Antiphospholipid Syndrome | 1 | 2020 | 166 | 0.160 |
Why?
|
Resource Allocation | 1 | 2021 | 354 | 0.160 |
Why?
|
Data Interpretation, Statistical | 1 | 2009 | 2708 | 0.160 |
Why?
|
Quarantine | 1 | 2021 | 186 | 0.160 |
Why?
|
Databases, Factual | 4 | 2021 | 8082 | 0.160 |
Why?
|
beta-Lactamases | 2 | 2019 | 307 | 0.150 |
Why?
|
Polymorphism, Genetic | 2 | 2021 | 4248 | 0.150 |
Why?
|
Europe | 3 | 2020 | 3437 | 0.150 |
Why?
|
Gene Flow | 3 | 2016 | 79 | 0.150 |
Why?
|
British Columbia | 1 | 2018 | 240 | 0.150 |
Why?
|
Mutagenesis, Insertional | 1 | 2021 | 661 | 0.150 |
Why?
|
Vaccines, Inactivated | 1 | 2018 | 186 | 0.150 |
Why?
|
Intercellular Adhesion Molecule-1 | 1 | 2002 | 1134 | 0.150 |
Why?
|
Health Care Rationing | 1 | 2021 | 435 | 0.150 |
Why?
|
Multigene Family | 4 | 2013 | 1081 | 0.140 |
Why?
|
United States | 11 | 2021 | 73027 | 0.140 |
Why?
|
Asymptomatic Diseases | 1 | 2020 | 590 | 0.140 |
Why?
|
Sierra Leone | 1 | 2017 | 171 | 0.140 |
Why?
|
Sentinel Surveillance | 2 | 2011 | 292 | 0.140 |
Why?
|
Alleles | 6 | 2016 | 6894 | 0.140 |
Why?
|
DNA | 3 | 2018 | 7213 | 0.140 |
Why?
|
Transformation, Bacterial | 1 | 2017 | 79 | 0.140 |
Why?
|
Phylogeography | 3 | 2012 | 72 | 0.140 |
Why?
|
Antibody Formation | 2 | 2018 | 1392 | 0.140 |
Why?
|
Mutation | 8 | 2021 | 30211 | 0.140 |
Why?
|
RNA, Ribosomal, 18S | 1 | 2016 | 54 | 0.130 |
Why?
|
Neutropenia | 1 | 2002 | 892 | 0.130 |
Why?
|
Public Policy | 1 | 2020 | 552 | 0.130 |
Why?
|
Viruses | 1 | 2020 | 373 | 0.130 |
Why?
|
Linkage Disequilibrium | 2 | 2020 | 1997 | 0.130 |
Why?
|
Campylobacter jejuni | 2 | 2014 | 24 | 0.130 |
Why?
|
Clone Cells | 2 | 2017 | 1669 | 0.130 |
Why?
|
Software | 5 | 2009 | 4478 | 0.130 |
Why?
|
Staphylococcal Skin Infections | 1 | 2016 | 78 | 0.130 |
Why?
|
Travel | 2 | 2020 | 805 | 0.120 |
Why?
|
Models, Statistical | 3 | 2021 | 5107 | 0.120 |
Why?
|
Peer Review, Research | 1 | 2018 | 344 | 0.120 |
Why?
|
Survival | 1 | 2015 | 160 | 0.120 |
Why?
|
Incidence | 6 | 2021 | 21532 | 0.120 |
Why?
|
Immunocompromised Host | 1 | 2020 | 863 | 0.120 |
Why?
|
Shock, Septic | 1 | 2002 | 774 | 0.120 |
Why?
|
DNA Restriction-Modification Enzymes | 1 | 2014 | 11 | 0.120 |
Why?
|
Meningitis, Bacterial | 1 | 2017 | 225 | 0.120 |
Why?
|
Soil Microbiology | 1 | 2015 | 92 | 0.120 |
Why?
|
Staphylococcus epidermidis | 1 | 2015 | 121 | 0.120 |
Why?
|
Quantitative Trait Loci | 2 | 2018 | 2131 | 0.120 |
Why?
|
Cefixime | 1 | 2014 | 13 | 0.110 |
Why?
|
Soft Tissue Infections | 1 | 2016 | 167 | 0.110 |
Why?
|
Cephalosporin Resistance | 1 | 2014 | 17 | 0.110 |
Why?
|
Virus Diseases | 1 | 2020 | 723 | 0.110 |
Why?
|
Genetic Loci | 3 | 2019 | 2629 | 0.110 |
Why?
|
Education, Graduate | 1 | 2014 | 75 | 0.110 |
Why?
|
HIV-1 | 2 | 2010 | 6960 | 0.110 |
Why?
|
Tropism | 1 | 2013 | 44 | 0.110 |
Why?
|
Entropy | 1 | 2014 | 211 | 0.110 |
Why?
|
Immunization | 1 | 2017 | 1218 | 0.110 |
Why?
|
Viral Load | 3 | 2020 | 3396 | 0.110 |
Why?
|
Drug Resistance, Multiple | 1 | 2014 | 255 | 0.110 |
Why?
|
Gene Rearrangement | 1 | 2018 | 1141 | 0.100 |
Why?
|
Gene Frequency | 3 | 2020 | 3623 | 0.100 |
Why?
|
Vaccines | 1 | 2021 | 842 | 0.100 |
Why?
|
Stochastic Processes | 1 | 2014 | 360 | 0.100 |
Why?
|
Infant, Newborn | 7 | 2018 | 26420 | 0.100 |
Why?
|
Sequence Homology, Nucleic Acid | 1 | 2013 | 1057 | 0.100 |
Why?
|
Hemolytic-Uremic Syndrome | 1 | 2013 | 106 | 0.100 |
Why?
|
Swine Diseases | 1 | 2012 | 61 | 0.100 |
Why?
|
Nasal Mucosa | 1 | 2015 | 416 | 0.100 |
Why?
|
Seasons | 1 | 2018 | 1524 | 0.100 |
Why?
|
Gambia | 1 | 2011 | 104 | 0.090 |
Why?
|
Enterococcus faecium | 1 | 2012 | 101 | 0.090 |
Why?
|
Vibrio cholerae O1 | 1 | 2013 | 243 | 0.090 |
Why?
|
Bacteriophages | 1 | 2014 | 382 | 0.090 |
Why?
|
Neisseria meningitidis | 3 | 2009 | 111 | 0.090 |
Why?
|
Pneumonia, Pneumococcal | 1 | 2012 | 133 | 0.090 |
Why?
|
Respiratory Syncytial Virus Infections | 1 | 2015 | 365 | 0.090 |
Why?
|
Genetic Heterogeneity | 1 | 2014 | 736 | 0.090 |
Why?
|
Animals | 11 | 2019 | 169222 | 0.090 |
Why?
|
Gram-Positive Bacteria | 1 | 2011 | 179 | 0.090 |
Why?
|
RNA, Ribosomal, 16S | 1 | 2014 | 1049 | 0.090 |
Why?
|
Reproducibility of Results | 3 | 2020 | 20218 | 0.090 |
Why?
|
Gene Pool | 1 | 2009 | 36 | 0.080 |
Why?
|
Fimbriae Proteins | 1 | 2010 | 133 | 0.080 |
Why?
|
Streptococcal Infections | 1 | 2014 | 618 | 0.080 |
Why?
|
Capsid | 1 | 2012 | 435 | 0.080 |
Why?
|
Gonorrhea | 1 | 2014 | 355 | 0.080 |
Why?
|
Extinction, Biological | 1 | 2009 | 30 | 0.080 |
Why?
|
History, 18th Century | 1 | 2009 | 206 | 0.080 |
Why?
|
Genetics, Microbial | 1 | 2009 | 53 | 0.080 |
Why?
|
Retrospective Studies | 7 | 2020 | 81746 | 0.080 |
Why?
|
Base Sequence | 3 | 2014 | 12418 | 0.080 |
Why?
|
Universities | 1 | 2014 | 1005 | 0.080 |
Why?
|
Typhoid Fever | 1 | 2010 | 195 | 0.080 |
Why?
|
Capsid Proteins | 1 | 2012 | 468 | 0.080 |
Why?
|
Health Status Disparities | 1 | 2020 | 1885 | 0.080 |
Why?
|
Proteome | 1 | 2018 | 1890 | 0.080 |
Why?
|
Burkholderia | 1 | 2008 | 35 | 0.080 |
Why?
|
Male | 20 | 2020 | 364641 | 0.080 |
Why?
|
Complement System Proteins | 1 | 2011 | 738 | 0.080 |
Why?
|
Finland | 2 | 2008 | 609 | 0.080 |
Why?
|
Microarray Analysis | 1 | 2011 | 753 | 0.080 |
Why?
|
Sequence Analysis | 1 | 2009 | 240 | 0.080 |
Why?
|
Time Factors | 6 | 2021 | 40214 | 0.070 |
Why?
|
Boston | 2 | 2020 | 9368 | 0.070 |
Why?
|
Virulence | 3 | 2010 | 1297 | 0.070 |
Why?
|
Fimbriae, Bacterial | 1 | 2008 | 138 | 0.070 |
Why?
|
Malawi | 2 | 2020 | 312 | 0.070 |
Why?
|
Molecular Sequence Data | 4 | 2013 | 17617 | 0.070 |
Why?
|
History, 19th Century | 1 | 2009 | 714 | 0.070 |
Why?
|
Health Personnel | 1 | 2021 | 3385 | 0.070 |
Why?
|
Female | 19 | 2020 | 397113 | 0.070 |
Why?
|
Predictive Value of Tests | 2 | 2020 | 15442 | 0.070 |
Why?
|
Cholera | 1 | 2013 | 754 | 0.070 |
Why?
|
Rabbits | 1 | 2013 | 4771 | 0.070 |
Why?
|
Repetitive Sequences, Nucleic Acid | 1 | 2009 | 781 | 0.070 |
Why?
|
Cytokines | 1 | 2002 | 7450 | 0.070 |
Why?
|
Africa | 2 | 2020 | 725 | 0.070 |
Why?
|
Conjunctivitis, Bacterial | 1 | 2006 | 22 | 0.060 |
Why?
|
Diarrhea | 1 | 2013 | 1320 | 0.060 |
Why?
|
Sensitivity and Specificity | 2 | 2020 | 14718 | 0.060 |
Why?
|
RNA, Viral | 3 | 2021 | 2871 | 0.060 |
Why?
|
Aged, 80 and over | 4 | 2020 | 59598 | 0.060 |
Why?
|
Young Adult | 9 | 2020 | 60048 | 0.060 |
Why?
|
Influenza A Virus, H1N1 Subtype | 1 | 2009 | 452 | 0.060 |
Why?
|
Conjunctivitis | 1 | 2006 | 153 | 0.060 |
Why?
|
Algorithms | 7 | 2017 | 14163 | 0.060 |
Why?
|
HIV Infections | 2 | 2010 | 17569 | 0.060 |
Why?
|
Genetic Linkage | 2 | 2010 | 2342 | 0.060 |
Why?
|
Age Factors | 2 | 2021 | 18407 | 0.060 |
Why?
|
Immunoglobulin G | 4 | 2018 | 4564 | 0.060 |
Why?
|
Students | 1 | 2014 | 1744 | 0.060 |
Why?
|
Selection Bias | 1 | 2005 | 360 | 0.060 |
Why?
|
Adult | 11 | 2020 | 223583 | 0.050 |
Why?
|
Phenotype | 2 | 2020 | 16723 | 0.050 |
Why?
|
Polysaccharides, Bacterial | 1 | 2006 | 582 | 0.050 |
Why?
|
Delivery of Health Care | 1 | 2021 | 5366 | 0.050 |
Why?
|
Reference Values | 1 | 2010 | 4938 | 0.050 |
Why?
|
Israel | 2 | 2020 | 726 | 0.050 |
Why?
|
Middle Aged | 9 | 2020 | 223422 | 0.050 |
Why?
|
Longitudinal Studies | 3 | 2018 | 14783 | 0.050 |
Why?
|
Aged | 7 | 2020 | 171446 | 0.050 |
Why?
|
Age Distribution | 2 | 2020 | 2871 | 0.050 |
Why?
|
History, 20th Century | 1 | 2009 | 2766 | 0.050 |
Why?
|
Program Evaluation | 1 | 2010 | 2506 | 0.050 |
Why?
|
INDEL Mutation | 2 | 2014 | 266 | 0.050 |
Why?
|
Prospective Studies | 5 | 2018 | 54924 | 0.050 |
Why?
|
Synteny | 1 | 2021 | 77 | 0.050 |
Why?
|
Adolescent | 7 | 2018 | 89155 | 0.050 |
Why?
|
Virus Shedding | 1 | 2021 | 110 | 0.050 |
Why?
|
Ships | 1 | 2020 | 53 | 0.040 |
Why?
|
Drug Resistance | 1 | 2006 | 1598 | 0.040 |
Why?
|
Rhode Island | 1 | 2021 | 352 | 0.040 |
Why?
|
Cohort Studies | 2 | 2019 | 41749 | 0.040 |
Why?
|
Macrolides | 1 | 2021 | 204 | 0.040 |
Why?
|
Likelihood Functions | 2 | 2014 | 994 | 0.040 |
Why?
|
Chromosomes, Bacterial | 1 | 2021 | 281 | 0.040 |
Why?
|
Immunization, Passive | 1 | 2022 | 619 | 0.040 |
Why?
|
Germany | 1 | 2021 | 883 | 0.040 |
Why?
|
Aluminum Hydroxide | 1 | 2018 | 55 | 0.040 |
Why?
|
Trans-Activators | 1 | 2008 | 2857 | 0.040 |
Why?
|
Operon | 2 | 2010 | 371 | 0.040 |
Why?
|
Cross-Sectional Studies | 2 | 2017 | 26375 | 0.040 |
Why?
|
Interleukin-1 | 1 | 2002 | 1252 | 0.040 |
Why?
|
Middle East | 1 | 2018 | 233 | 0.040 |
Why?
|
Metagenome | 1 | 2021 | 465 | 0.040 |
Why?
|
Mosaicism | 1 | 2021 | 480 | 0.040 |
Why?
|
Penicillin-Binding Proteins | 1 | 2018 | 152 | 0.040 |
Why?
|
Protein Array Analysis | 1 | 2018 | 399 | 0.030 |
Why?
|
Tetracycline Resistance | 1 | 2016 | 22 | 0.030 |
Why?
|
Acinetobacter | 1 | 2016 | 39 | 0.030 |
Why?
|
Gene Deletion | 2 | 2016 | 2673 | 0.030 |
Why?
|
Internet | 1 | 2009 | 3110 | 0.030 |
Why?
|
Adhesins, Bacterial | 1 | 2017 | 118 | 0.030 |
Why?
|
Point Mutation | 1 | 2001 | 1594 | 0.030 |
Why?
|
Sweden | 1 | 2019 | 1382 | 0.030 |
Why?
|
Mutagens | 1 | 2016 | 181 | 0.030 |
Why?
|
Fatal Outcome | 1 | 2020 | 1836 | 0.030 |
Why?
|
Probability | 1 | 2021 | 2479 | 0.030 |
Why?
|
Ecological and Environmental Phenomena | 1 | 2015 | 10 | 0.030 |
Why?
|
Arctic Regions | 1 | 2015 | 25 | 0.030 |
Why?
|
Asia | 1 | 2016 | 629 | 0.030 |
Why?
|
Genome-Wide Association Study | 1 | 2014 | 12795 | 0.030 |
Why?
|
Sex Distribution | 1 | 2020 | 2276 | 0.030 |
Why?
|
Chloramphenicol Resistance | 1 | 2014 | 6 | 0.030 |
Why?
|
DNA, Single-Stranded | 1 | 2016 | 351 | 0.030 |
Why?
|
Polymerase Chain Reaction | 1 | 2004 | 6071 | 0.030 |
Why?
|
Placebos | 1 | 2018 | 1667 | 0.030 |
Why?
|
Soil | 1 | 2015 | 120 | 0.030 |
Why?
|
Iceland | 1 | 2014 | 183 | 0.030 |
Why?
|
Genome, Fungal | 1 | 2015 | 203 | 0.030 |
Why?
|
Genetic Fitness | 1 | 2015 | 120 | 0.030 |
Why?
|
Genes, Fungal | 1 | 2015 | 440 | 0.030 |
Why?
|
Birds | 1 | 2014 | 166 | 0.030 |
Why?
|
Haplotypes | 1 | 2020 | 2722 | 0.030 |
Why?
|
Adjuvants, Immunologic | 1 | 2018 | 998 | 0.030 |
Why?
|
Gene Order | 1 | 2013 | 166 | 0.030 |
Why?
|
Genome | 1 | 2021 | 1754 | 0.030 |
Why?
|
Acute Disease | 1 | 2004 | 7241 | 0.030 |
Why?
|
Heat-Shock Proteins | 1 | 2017 | 797 | 0.030 |
Why?
|
New York City | 1 | 2015 | 737 | 0.030 |
Why?
|
Up-Regulation | 1 | 2002 | 4146 | 0.030 |
Why?
|
Odds Ratio | 1 | 2005 | 9666 | 0.030 |
Why?
|
Turkey | 1 | 2012 | 256 | 0.020 |
Why?
|
Cytoplasm | 1 | 2016 | 1505 | 0.020 |
Why?
|
Chickens | 1 | 2014 | 845 | 0.020 |
Why?
|
New Mexico | 1 | 2011 | 81 | 0.020 |
Why?
|
Arizona | 1 | 2011 | 108 | 0.020 |
Why?
|
California | 1 | 2016 | 1438 | 0.020 |
Why?
|
Streptococcus Phages | 1 | 2011 | 4 | 0.020 |
Why?
|
Complement C1q | 1 | 2011 | 93 | 0.020 |
Why?
|
Haiti | 1 | 2013 | 553 | 0.020 |
Why?
|
Drug Resistance, Microbial | 1 | 2014 | 830 | 0.020 |
Why?
|
Membrane Transport Proteins | 1 | 2017 | 1037 | 0.020 |
Why?
|
Enterococcus faecalis | 1 | 2012 | 244 | 0.020 |
Why?
|
Antigenic Variation | 1 | 2011 | 117 | 0.020 |
Why?
|
Consensus | 1 | 2020 | 3210 | 0.020 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2002 | 4351 | 0.020 |
Why?
|
Epitopes | 1 | 2017 | 2526 | 0.020 |
Why?
|
Neisseria lactamica | 1 | 2009 | 1 | 0.020 |
Why?
|
Cause of Death | 1 | 2020 | 3720 | 0.020 |
Why?
|
Linear Models | 1 | 2020 | 5884 | 0.020 |
Why?
|
DNA Replication | 1 | 2016 | 1427 | 0.020 |
Why?
|
Viridans Streptococci | 1 | 2009 | 16 | 0.020 |
Why?
|
Mortality | 1 | 2020 | 2910 | 0.020 |
Why?
|
Salmonella typhi | 1 | 2010 | 200 | 0.020 |
Why?
|
Logistic Models | 2 | 2017 | 13289 | 0.020 |
Why?
|
Peer Group | 1 | 2014 | 702 | 0.020 |
Why?
|
Risk Assessment | 1 | 2010 | 24314 | 0.020 |
Why?
|
Evidence-Based Medicine | 1 | 2020 | 3701 | 0.020 |
Why?
|
Cattle | 1 | 2014 | 3819 | 0.020 |
Why?
|
Child Day Care Centers | 1 | 2009 | 122 | 0.020 |
Why?
|
Interprofessional Relations | 1 | 2014 | 997 | 0.020 |
Why?
|
Nasal Cavity | 1 | 2009 | 310 | 0.020 |
Why?
|
Gene Duplication | 1 | 2008 | 315 | 0.020 |
Why?
|
Mexico | 1 | 2009 | 769 | 0.020 |
Why?
|
Bacterial Adhesion | 1 | 2008 | 305 | 0.020 |
Why?
|
Electrophoresis, Gel, Pulsed-Field | 1 | 2006 | 142 | 0.020 |
Why?
|
Disease Models, Animal | 1 | 2006 | 18344 | 0.020 |
Why?
|
Bacterial Physiological Phenomena | 1 | 2007 | 120 | 0.020 |
Why?
|
Cells, Cultured | 1 | 2002 | 19017 | 0.020 |
Why?
|
Multivariate Analysis | 2 | 2009 | 12075 | 0.020 |
Why?
|
Immunoenzyme Techniques | 1 | 2008 | 1698 | 0.020 |
Why?
|
Uganda | 1 | 2010 | 1361 | 0.020 |
Why?
|
Family Characteristics | 1 | 2010 | 1003 | 0.010 |
Why?
|
Learning | 1 | 2014 | 1759 | 0.010 |
Why?
|
Family Health | 1 | 2009 | 1255 | 0.010 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2011 | 3813 | 0.010 |
Why?
|
Adaptation, Physiological | 1 | 2011 | 1311 | 0.010 |
Why?
|
Monte Carlo Method | 1 | 2009 | 1259 | 0.010 |
Why?
|
Recurrence | 1 | 2016 | 8507 | 0.010 |
Why?
|
Genome, Human | 1 | 2016 | 4443 | 0.010 |
Why?
|
Information Storage and Retrieval | 1 | 2008 | 830 | 0.010 |
Why?
|
Disease Susceptibility | 1 | 2009 | 1793 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2020 | 15944 | 0.010 |
Why?
|
Epithelial Cells | 1 | 2014 | 3703 | 0.010 |
Why?
|
Pattern Recognition, Automated | 1 | 2008 | 993 | 0.010 |
Why?
|
Swine | 1 | 2012 | 5994 | 0.010 |
Why?
|
Flow Cytometry | 1 | 2011 | 5902 | 0.010 |
Why?
|
Cell Line | 1 | 2014 | 15597 | 0.010 |
Why?
|
Health Surveys | 1 | 2010 | 4056 | 0.010 |
Why?
|
Membrane Proteins | 1 | 2017 | 7876 | 0.010 |
Why?
|
Protein Binding | 1 | 2011 | 9343 | 0.010 |
Why?
|
Neutrophils | 1 | 2011 | 3786 | 0.010 |
Why?
|
Biomedical Research | 1 | 2014 | 3463 | 0.010 |
Why?
|
Risk Factors | 2 | 2019 | 74936 | 0.010 |
Why?
|
Hospitalization | 1 | 2015 | 10840 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2017 | 39345 | 0.010 |
Why?
|
Mice | 1 | 2015 | 82024 | 0.000 |
Why?
|